Assessing the methodological strengths and limitations of the Spanish Society of Medical Oncology (SEOM) guidelines: a critical appraisal using AGREE II and AGREE-REX tool.


Por: Santero M., de Mas J., Rifà B., Clavero I., Rexach I., Cosp, XB

Publicada: 1 ene 2024 Ahead of Print: 1 jun 2023
Resumen:
The Spanish Society of Medical Oncology (SEOM) has provided open-access guidelines for cancer since 2014. However, no independent assessment of their quality has been conducted to date. This study aimed to critically evaluate the quality of SEOM guidelines on cancer treatment.

Filiaciones:
Santero M.:
 Univ Autonoma Barcelona UAB, Barcelona, Spain

de Mas J.:
 Univ Autonoma Barcelona UAB, Barcelona, Spain

Rifà B.:
 Univ Autonoma Barcelona UAB, Barcelona, Spain

Clavero I.:
 Univ Autonoma Barcelona UAB, Barcelona, Spain

Rexach I.:
 Univ Autonoma Barcelona UAB, Barcelona, Spain

Cosp, XB:
 Univ Autonoma Barcelona UAB, Barcelona, Spain

 Biomed Res Inst St Pau IIB St Pau, Iberoamerican Cochrane Ctr, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain
ISSN: 1699048X
Editorial
SPRINGER INTERNATIONAL PUBLISHING AG, GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND, España
Tipo de documento: Article
Volumen: https://ddd.uab.cat/recor Número: 1
Páginas: 85-97
WOS Id: 001017542000003
ID de PubMed: 37368198
imagen hybrid, All Open Access; Hybrid Gold

MÉTRICAS